Prior Art Status of Drug Standard Evidence in China's Pharmaceutical Patent Invalidation Process

Ji Yu; Guo Feixiang

首页> 外文期刊>Biotechnology Law Report >Prior Art Status of Drug Standard Evidence in China's Pharmaceutical Patent Invalidation Process

【24h】

Prior Art Status of Drug Standard Evidence in China's Pharmaceutical Patent Invalidation Process

机译：中国药品专利无效程序中药品标准证据的现有技术现状

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biotechnology Law Report》 |2016年第3期|共5页
作者
Ji Yu; Guo Feixiang;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类法律;生物科学;生物工程学（生物技术）;
关键词

相似文献

外文文献
中文文献
专利

1. Prior Art Status of Drug Standard Evidence in China's Pharmaceutical Patent Invalidation Process [J] . Ji Yu, Guo Feixiang Biotechnology Law Report . 2016,第3期

机译：中国药品专利无效程序中药品标准证据的现有技术现状
2. How patent signals affect venture capital: The evidence of bio-pharmaceutical start-ups in China [J] . Zhang Lili, Guo Ying, Sun Ganlu Technological forecasting and social change . 2019,第AUGa期

机译：专利信号如何影响风险投资：中国生物制药初创企业的证据
3. How patent signals affect venture capital: The evidence of bio-pharmaceutical start-ups in China [J] . Zhang Lili, Guo Ying, Sun Ganlu Technological forecasting and social change . 2019,第Auga期

机译：专利信号如何影响风险投资：中国生物药物初创企业的证据
4. Research on the Status quo of Anti-cancer Pharmaceutical Patents in China: Based on the Patent Analysis [C] . Jie-Jing YAO, Hui PENG International Conference on Management Science and Management Innovation . 2014

机译：中国抗癌药品专利现状研究 - 基于专利分析
5. Three Essays on Proprietary Rights and Innovation: Evidence from the Invalidated Gene Patents [D] . Khoshsokhan, Sina 2019

机译：关于所有权和创新的三篇论文：来自无效基因专利的证据
6. Obstacles to prior art searching by the trilateral patent offices: empirical evidence from International Search Reports [O] . Tetsuo Wada -1

机译：三边专利局进行现有技术检索的障碍：来自国际检索报告的经验证据
7. Research on the Status quo of Anti-cancer Pharmaceutical Patents in China: Based on the Patent Analysis [O] . Jie-Jing Yao, Hui Peng 2014

机译：中国抗癌药品专利现状研究 - 基于专利分析

Prior Art Status of Drug Standard Evidence in China's Pharmaceutical Patent Invalidation Process

著录项

相似文献

相关主题

期刊订阅